An increase of sigma1 receptors in the aged monkey brain

[1]  A. Privat,et al.  Sigma1 (σ 1) receptor agonists and neurosteroids attenuate β 25–35-amyloid peptide-induced amnesia in mice through a common mechanism , 1998, Neuroscience.

[2]  Lars Farde,et al.  Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain , 2000, Neurobiology of Aging.

[3]  M. Senda,et al.  Preclinical evaluation of [11C]SA4503: radiation dosimetry,in vivo selectivity and PET imaging of sigma1 receptors in the cat brain , 2000, Annals of nuclear medicine.

[4]  R. Quirion,et al.  [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: Autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes , 1997, Neuroscience.

[5]  M. Guttman.  Dopamine receptors in Parkinson's disease. , 1992, Neurologic clinics.

[6]  A. Urani,et al.  The interaction between neuroactive steroids and the σ1 receptor function: behavioral consequences and therapeutic opportunities , 2001, Brain Research Reviews.

[7]  Kiyoshi Matsuno,et al.  SA4503: A Novel Sigma1 Receptor Agonist , 1998 .

[8]  Edythe D. London,et al.  Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia , 1991, Biological Psychiatry.

[9]  O. Inoue,et al.  No age-related changes in human benzodiazepine receptor binding measured by PET with [11C]Ro 15-4513 , 1993, Neuroscience Letters.

[10]  T. Nabeshima,et al.  Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities. , 1999, Japanese journal of pharmacology.

[11]  J. Kornhuber,et al.  Characterization of [3H]pentazocine binding sites in post-mortem human frontal cortex , 2005, Journal of Neural Transmission.

[12]  Tetsuya Kobayashi,et al.  σ1 Receptor Subtype Is Involved in the Facilitation of Cortical Dopaminergic Transmission in the Rat Brain , 1997, Neurochemical Research.

[13]  G. Fillion,et al.  Autoradiographic study of neurosteroid binding sites labelled with [35S]-TBPS in brain of different species , 1993, Brain Research Bulletin.

[14]  G. Gudelsky.  Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat , 1999, Journal of Neural Transmission.

[15]  Charles F. Reynolds,et al.  Reduced binding of [ 18 F ]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction , 1998, Brain Research.

[16]  Su Tp,et al.  Delineating biochemical and functional properties of sigma receptors: emerging concepts. , 1993 .

[17]  W. Bowen,et al.  Sigma receptors: biology and function. , 1990, Pharmacological reviews.

[18]  D. Mash,et al.  Sigma receptors are associated with cortical limbic areas in the primate brain , 1992, Synapse.

[19]  M. Senda,et al.  Mapping of sigma1 receptors in living human brain , 2001, NeuroImage.

[20]  N. Harada,et al.  Age-related changes in muscarinic cholinergic receptors in the living brain: a PET study using N-[11C]methyl-4-piperidyl benzilate combined with cerebral blood flow measurement in conscious monkeys , 2001, Brain Research.

[21]  Hideo Tsukada,et al.  Age-related reduction of [11C]MDL100,907 binding to central 5-HT2A receptors: PET study in the conscious monkey brain , 2000, Brain Research.

[22]  Shitij Kapur,et al.  Serotonin 5-HT1A Receptor Binding Potential Declines with Age as Measured by [11C]WAY-100635 and PET , 2001, Neuropsychopharmacology.

[23]  Steven G. Potkin,et al.  Decrease in σ but no increase in striatal dopamine D4 sites in schizophrenic brains , 1996 .

[24]  K. Jansen,et al.  Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer's disease correlates with CA1 pyramidal cell loss , 1993, Brain Research.

[25]  K. Leenders,et al.  Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride. , 1993, Archives of neurology.

[26]  Kyung-Han Lee,et al.  Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein kinase C. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  S. Hjorth,et al.  3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. , 1981, Life sciences.

[28]  N. Harada,et al.  Effects of aging on 5‐HT1A receptors and their functional response to 5‐HT1a agonist in the living brain: PET study with [carbonyl‐11C]WAY‐100635 in conscious monkeys , 2001, Synapse.

[29]  N. Orentreich,et al.  Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. , 1984, The Journal of clinical endocrinology and metabolism.

[30]  D. Swaab,et al.  Increased expression of estrogen receptor α and β in the nucleus basalis of Meynert in Alzheimer’s disease , 2001, Neurobiology of Aging.

[31]  Masaomi Iyo,et al.  The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain , 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  Junien Jl,et al.  Drugs acting on sigma and phencyclidine receptors: a review of their nature, function, and possible therapeutic importance. , 1989 .

[33]  K. Leenders,et al.  Long‐term changes of striatal dopamine D2 Receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]Raclopride , 1997, Movement disorders : official journal of the Movement Disorder Society.

[34]  U Ruotsalainen,et al.  Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]Raclopride , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  Yoichi Kawashima,et al.  Binding properties of SA4503, a novel and selective σ1 receptor agonist , 1996 .

[36]  Kiichi Ishiwata,et al.  In vivo evaluation of [11C]SA4503 as a PET ligand for mapping CNS sigma1 receptors , 2000 .

[37]  N. Volkow,et al.  Age‐related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET) , 1990, Journal of neuroscience research.

[38]  E. London,et al.  Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. , 1988, Science.

[39]  J S Fowler,et al.  Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. , 1995, Life sciences.

[40]  A. Privat,et al.  SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice. , 1997, European journal of pharmacology.

[41]  N. Harada,et al.  Age differences in muscarinic cholinergic receptors assayed with (+)N‐[11C]methyl‐3‐piperidyl benzilate in the brains of conscious monkeys , 2001, Synapse.

[42]  R J Wyatt,et al.  In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long‐term MPTP‐induced parkinsonism , 2000, Synapse.

[43]  R. Waterhouse,et al.  Synthesis of [18F]-1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)-piperidine : A potential sigma-1 receptor radioligand for PET , 1996 .

[44]  L. Werling,et al.  Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and σ receptor ligands , 1997, Brain Research.

[45]  N L Foster,et al.  Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET , 2001, Synapse.

[46]  K. Matsuno,et al.  Regional differences of the effect of σ receptor ligands on the acetylcholine release in the rat brain , 2005, Journal of Neural Transmission.

[47]  M. Senda,et al.  Mapping of the Sigma1 Receptors in the Primate Brain by PET with [11C]SA4503 , 2002 .

[48]  M. Laruelle,et al.  Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights. , 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[49]  Hideo Tsukada,et al.  Mapping of CNS sigma1 receptors in the conscious monkey: Preliminary PET study with [11C]SA4503 , 2001, Synapse.

[50]  P. Cristofori,et al.  Influence of N-allyl-normetazocine on acetylcholine release from brain slices: involvement of muscarinic receptors , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

[51]  D. Wallace,et al.  Sigma binding sites identified by [3H] DTG are elevated in aged Fischer‐344 × Brown Norway (F1) rats , 2000, Synapse.

[52]  W. Bowen,et al.  Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons , 1989, Synapse.

[53]  K. Meguro,et al.  Age-dependent decrease in histamine H1 receptor in human brains revealed by PET. , 1992, Neuroreport.

[54]  S Tanada,et al.  Age-related reduction of extrastriatal dopamine D2 receptor measured by PET. , 2001, Life sciences.

[55]  I. Ulus,et al.  Age-Related Alterations In Pre-Synaptic and Receptor-Mediated Cholinergic Functions In Rat Brain , 1998, Neurochemical Research.

[56]  Tetsuya Kobayashi,et al.  Involvement of σ1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats , 1995, Brain Research.

[57]  R. Roth,et al.  Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study , 1998, Brain Research.